SynthesisCardiovascular drugs and therapy2021

Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4-5 Chronic Kidney Disease or on Dialysis.

Chen Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.